NowPatient Partners with Infermedica to improve access to treatments

January 29, 2025 09:53 PM +04 | By EIN Presswire
 NowPatient Partners with Infermedica to improve access to treatments
Image source: EIN Presswire
LONDON, UNITED KINGDOM, January 29, 2025 /EINPresswire.com/ -- NowPatient, a leading global online pharmacy & telehealth service, is excited to announce its new partnership with Infermedica, the global frontrunner in AI-powered medical device symptom checkers and virtual triage. This landmark collaboration will see NowPatient’s industry leading virtual care platform integrate with Infermedica’s advanced AI-driven symptoms checking technology, marking a significant step forward in delivering cutting-edge healthcare tools to users worldwide.

The partnership will empower NowPatient’s users to access Infermedica’s clinically validated and CE-marked symptom checker, powered with AI and extensive medical knowledge. This tool enables individuals to assess their symptoms, understand possible conditions, and receive guidance on the next steps for care—such as visiting a healthcare professional or self-triaging to seamlessly access urgent treatments using NowPatient’s virtual care treatment pathways.

By incorporating Infermedica API, NowPatient reinforces its commitment to providing innovative digital healthcare solutions that are both accessible and easy to use. Infermedica’s digital tools, already trusted by over 20 million users globally, combines a vast database of medical knowledge with state-of-the-art algorithms to ensure users receive case-adjusted, reliable information at their fingertips.

Rajive Patel, Product Lead of NowPatient, commented:
“We are thrilled to partner with Infermedica to enhance our Symptom Checker service. Integrating their best-in-class AI medical device into NowPatient virtual care pathways aligns perfectly with our mission to make healthcare accessible, simple, and proactive for everyone. This partnership ensures that our users will benefit from an industry-leading tool, empowering them to take control of their health decisions like never before.”

Piotr Orzechowski, CEO of Infermedica, said:
"We are excited to collaborate with NowPatient to expand access to reliable, clinically validated digital health tools. By integrating our AI-powered symptom checker into NowPatient's virtual care pathways, we are taking a step toward empowering individuals to make informed health decisions and access care more efficiently. This partnership represents a shared commitment to leveraging technology to improve healthcare accessibility and outcomes worldwide."

For more information about the partnership and upcoming developments, visit www.nowpatient.com or www.infermedica.com

Media Contacts:
NowPatient
Daniel Warner
Email: [email protected]
Phone: +44 203 885 1500

Infermedica
Jenn Hand
Email: [email protected]

About NowPatient:
NowPatient is a leader in digital healthcare, offering innovative tools and solutions to make healthcare accessible to everyone. With a focus on affordability and ease of use, NowPatient provides medication delivery, telehealth services, and health management tools to users worldwide.

About Infermedica :
Infermedica is a global leader in AI-powered symptom analysis and patient triage, dedicated to making healthcare more accessible, accurate, and convenient by automating primary care. Operating in over 30 countries and 24 languages, its solutions have powered over 20 million health checks since 2012. Learn more at www.infermedica.com.

Daniel Warner
NowPatient
+44 20 3885 1500
[email protected]
Visit us on social media:
Facebook
X
Instagram

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.